From major journals, first or last author from the Institute for Cancer Research
Apsana L, Benedikte AS, Unni N, Jayne KN, Je SR, Geir B, Kristine P(2025) A role of arginase-1-expressing myeloid cells in cachexia Cancer Metab, 13(1), 27 DOI 10.1186/s40170-025-00396-0, PubMed 40474277
Andresen S, Al Outa A, Formica M, Enserink J, Knævelsrud H(2025) Improved detection of lipidated Atg8a by immunoblotting in drosophila melanogaster cells and tissues enables precise investigation of Atg8a flux and its termination Autophagy(in press) DOI 10.1080/15548627.2025.2508551, PubMed 40426043
Høyvik AJK, Kvassheim M, Ma LW, Wiig E, Hillestad T, Revheim ME, Liukaityte R, Bruland Ø, Juzeniene A(2025) Therapeutic evaluation of [212Pb]Pb-AB001 and [177Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer Eur J Nucl Med Mol Imaging(in press) DOI 10.1007/s00259-025-07330-y, PubMed 40397137
Bouska A, Zhang W, Sharma S, Holte H, Shah RA, Lone WG, Soma MA, Yang R, Liu X, Mehmood S, Chawla RS, Cappelli LV, Fiore D, Gong Q, Heavican-Foral TB, Cannatella JJ, Amador C, Arif A, Smith LM, Lim ST, Ong CK, Feldman AL, Du MQ, Perry AM, de Leval Let al.(2025) Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma Am J Hematol(in press) DOI 10.1002/ajh.27736, PubMed 40510016
Al Haidari G, Solbakken AM, Åsli LM, Skovlund E, Undseth C, Guren MG(2025) Treatment and outcomes for locally recurrent rectal cancer in Norway Acta Oncol, 64, 784-792 DOI 10.2340/1651-226X.2025.42991, PubMed 40500960
Lindland K, Westrøm S, Dragovic SM, Li RG, Malenge MM, Ho B, Juzeniene A, Bønsdorff TB(2025) Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy Mol Cancer Ther(in press) DOI 10.1158/1535-7163.MCT-24-1060, PubMed 40495114